{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:40:45Z","timestamp":1793259645830,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To develop a model for early identification of coagulopathy in septic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with sepsis were identified from the Medical Information Mart for Intensive Care (MIMIC)-IV database. Patients who did not meet the sepsis-induced coagulopathy (SIC) scoring criteria upon admission but developed SIC within the subsequent 7 days were considered to be in a pre-SIC state at baseline. Baseline clinical features of the patients were screened by lasso regression. Subsequently, these features underwent multivariate logistic regression for model construction, followed by testing the stability of the model in the test set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 7,806 patients were included in the study from the MIMIC-IV database, comprising 7,080 without SIC and 726 with pre-SIC. Patients with pre-SIC had higher criticality scores compared to patients with Non-SIC. Pre-SIC was identified as an independent risk factor for hospitalization, 28-day, 90-day, and 1-year mortality in patients with sepsis. Patients with pre-SIC who received early heparin had lower 28-day mortality compared to those without treatment. The SIC scoring system demonstrated a sensitivity of 77.0% for identifying pre-SIC, a specificity of 53.9%, and an AUC of 0.694 (95% CI: 0.659\u20130.730). Based on SIC scoring system, additional clinical features were added to the pre-SIC model, ultimately yielding 70% sensitivity and 76.2% specificity with an AUC of 0.802 (95% CI: 0.773\u20130.830) in the validation set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The development of SIC is associated with increased mortality rate in patients with sepsis, and precise identification of this group of patients and individualized treatment may be important for improving prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11482-5","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:48:05Z","timestamp":1756201685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early identification of sepsis-induced coagulopathy in critical ill patients: an analysis from MIMIC IV database"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiming","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"5","key":"11482_CR1","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1378\/chest.12-2112","volume":"143","author":"B Singh","year":"2013","unstructured":"Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, et al. Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004\u20132010): a population-based study. Chest. 2013;143(5):1235\u201342.","journal-title":"Chest"},{"issue":"9","key":"11482_CR2","doi-asserted-by":"publisher","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.","journal-title":"BMJ Open"},{"issue":"6","key":"11482_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s00134-016-4257-z","volume":"42","author":"S Gando","year":"2016","unstructured":"Gando S, Meziani F, Levi M. What\u2019s new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med. 2016;42(6):1062\u20134.","journal-title":"Intensive Care Med"},{"issue":"7","key":"11482_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0885066618773679","volume":"35","author":"T Iba","year":"2020","unstructured":"Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, et al. Newly proposed Sepsis-Induced coagulopathy precedes international society on thrombosis and haemostasis Overt-Disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35(7):643\u20139.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"11482_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-0038-1676610","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa K, Yoshimura J, Ito T, Hayakawa M, Hamasaki T, Fujimi S. External validation of the two newly proposed criteria for assessing coagulopathy in sepsis. Thromb Haemost. 2019;119(2):203\u201312.","journal-title":"Thromb Haemost"},{"issue":"9","key":"11482_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","volume":"41","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, et al. A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of Recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41(9):2069\u201379.","journal-title":"Crit Care Med"},{"issue":"20","key":"11482_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with Sepsis-Associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321(20):1993\u20132002.","journal-title":"JAMA"},{"issue":"1","key":"11482_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0038-1676345","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019;119(1):56\u201365.","journal-title":"Thromb Haemost"},{"issue":"23","key":"11482_CR9","doi-asserted-by":"publisher","first-page":"E215","DOI":"10.1161\/01.CIR.101.23.e215","volume":"101","author":"AL Goldberger","year":"2000","unstructured":"Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, et al. PhysioBank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):E215-20.","journal-title":"Circulation"},{"key":"11482_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350: g7594.","journal-title":"BMJ"},{"issue":"8","key":"11482_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"12","key":"11482_CR12","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1016\/j.jtha.2023.05.028","volume":"21","author":"T Iba","year":"2023","unstructured":"Iba T, Helms J, Neal MD, Levy JH. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. J Thromb Haemost. 2023;21(12):3360\u201370.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"11482_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-022-01093-7","volume":"13","author":"T Schmoch","year":"2023","unstructured":"Schmoch T, M\u00f6hnle P, Weigand MA, Briegel J, Bauer M, Bloos F, et al. The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials. Ann Intensive Care. 2023;13(1):3.","journal-title":"Ann Intensive Care"},{"key":"11482_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkac029","volume":"10","author":"ZY Zou","year":"2022","unstructured":"Zou ZY, Huang JJ, Luan YY, Yang ZJ, Zhou ZP, Zhang JJ, et al. Early prophylactic anticoagulation with heparin alleviates mortality in critically ill patients with sepsis: a retrospective analysis from the MIMIC-IV database. Burns Trauma. 2022;10: tkac029.","journal-title":"Burns Trauma"},{"key":"11482_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.thromres.2023.05.009","volume":"226","author":"H Kato","year":"2023","unstructured":"Kato H, Hagihara M, Asai N, Umemura T, Hirai J, Mori N, et al. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - a meta-analysis. Thromb Res. 2023;226:165\u201372.","journal-title":"Thromb Res"},{"issue":"3","key":"11482_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3892\/etm.2013.1466","volume":"7","author":"XL Liu","year":"2014","unstructured":"Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y, Lu F, et al. Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study. Exp Ther Med. 2014;7(3):604\u20138.","journal-title":"Exp Ther Med"},{"key":"11482_CR17","doi-asserted-by":"publisher","first-page":"1173893","DOI":"10.3389\/fphar.2023.1173893","volume":"14","author":"JJ Huang","year":"2023","unstructured":"Huang JJ, Zou ZY, Zhou ZP, Liu Y, Yang ZJ, Zhang JJ, et al. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. Front Pharmacol. 2023;14:1173893.","journal-title":"Front Pharmacol"},{"key":"11482_CR18","unstructured":"!!! INVALID CITATION !!!."},{"issue":"7","key":"11482_CR19","first-page":"309","volume":"13","author":"C Zilkens","year":"2008","unstructured":"Zilkens C, Friese J, K\u00f6ller M, Muhr G, Schinkel C. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis? Eur J Med Res. 2008;13(7):309\u201313.","journal-title":"Eur J Med Res"},{"issue":"7","key":"11482_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/jth.12596","volume":"12","author":"T Iba","year":"2014","unstructured":"Iba T, Gando S, Thachil J. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost. 2014;12(7):1010\u20139.","journal-title":"J Thromb Haemost"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11482-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:39:56Z","timestamp":1781609996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-11482-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11482"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11482-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1071"}}